Showing 1 - 10 of 16 for "" with applied filters
14 November 2024 by
Han Kun Releases 2022-2023 Fund Practice Data Analysis Report
25 October 2024 by
The National Financial Regulatory Administration (“NFRA”) issued the Administrative Measures for Syndicated Loan Business (“Administrative Measures”) on 12 October 2024, which will take effect from 1 November 2024 and shall amend and replace the Guidelines on Syndicated Loan Business issued by the China Banking Regulatory Commission on 1 August 2011 (the “Business Guidelines”).
11 September 2024 by
On September 8, 2024, the Ministry of Commerce, together with the National Health Commission and the National Medical Products Administration publicly issued the Notice on Carrying Out Pilot Programs to Expand Opening-Up in the Healthcare Sector
30 July 2024 by
Onshore Transactions Continued their Upward Trend while VIE Structure Lost Luster for Offshore Transactions
29 May 2024 by
Han Kun advises on JD.com, Inc.'s US$ 2.0 billion convertible senior notes offering
06 March 2024 by
Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq
05 January 2024 by
Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).
04 January 2024 by
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
03 January 2024 by
ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China
18 September 2023 by
Onshore Transactions Continued their Upward Trend, the Biomedical Sector Remained the Most Popular Investment Destination
